STREAMING NOW: Watch Now

FDA approves new drug for migraine sufferers

The US Food and Drug Administration on Monday...

Posted: Dec 24, 2019 9:45 AM

The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.

The drug will be sold under the name Ubrelvy by the pharmaceutical company Allergan. It is considered effective for migraine with or without aura, referring to the sensory or visual disturbances that occur among roughly a third of migraine sufferers.

"Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication," Dr. Billy Dunn, acting director of the Office of Neuroscience in the FDA's Center for Drug Evaluation and Research, said in a statement Monday.

In a study published last month, the drug showed greater rates of pain and symptom relief from migraine compared to a placebo, with more than 19% of participants given the drug reporting to be pain-free within two hours and nearly 40% relieved of the most bothersome symptoms linked to migraine, which include light and noise sensitivity. This is compared to roughly 12% and 28%, respectively, from the placebo. Nausea, sleepiness and dry mouth were the most commonly reported side effects.

Some migraines can be treated with over-the-counter medications such as ibuprofen, acetaminophen or aspirin, if taken at the first signs of a migraine occurring. When these aren't effective, the most commonly prescribed treatment is a class of drugs called triptans, which are considered more effective than ubrogepant but have a catch: They work by constricting blood vessels around the brain to stop the pain, so they are not considered safe for use by people at risk of cardiovascular disease and stroke. The newly approved drug, on the other hand, has a different molecular target -- a protein involved in the transmission of pain.

An estimated 40 million Americans and 1 billion people worldwide suffer from migraines. The condition affects one in five women and one in 16 men, according to the American Migraine Foundation.

New York Coronavirus Cases

County data is updated nightly.

Cases: 2140258

Reported Deaths: 53611
CountyCasesDeaths
Kings28613110512
Queens28134210016
Suffolk2034473410
Nassau1863713184
Bronx1860246595
New York1419364526
Westchester1309682295
Erie903471814
Richmond767401851
Monroe697391117
Orange48855847
Rockland47345758
Onondaga39348680
Dutchess29771447
Albany24943358
Oneida22785517
Niagara20199375
Broome18764367
Saratoga15621168
Ulster14074258
Schenectady13309205
Rensselaer11370145
Putnam1070593
Chautauqua8997146
Chemung7834137
Oswego768393
Ontario748493
Steuben7003147
Sullivan674476
St. Lawrence673197
Cayuga640392
Jefferson624168
Wayne583273
Cattaraugus576793
Genesee5453124
Herkimer5242110
Clinton487033
Madison460389
Livingston455360
Fulton445393
Tompkins439652
Montgomery4281128
Columbia4118104
Cortland395864
Tioga386263
Warren374562
Wyoming361853
Allegany357687
Chenango353677
Otsego348247
Greene346179
Washington319055
Orleans314283
Lewis283236
Franklin257212
Delaware241539
Seneca202657
Schoharie172219
Essex162526
Yates118226
Schuyler108814
Hamilton3162
Unassigned8812
Out of NY0252
Utica
Cloudy
60° wxIcon
Hi: 75° Lo: 58°
Feels Like: 60°
Oneonta
Cloudy
60° wxIcon
Hi: 74° Lo: 59°
Feels Like: 60°
Herkimer
Cloudy
60° wxIcon
Hi: 75° Lo: 59°
Feels Like: 60°
Old Forge
Cloudy
60° wxIcon
Hi: 72° Lo: 57°
Feels Like: 60°
WKTV Radar
WKTV Temperatures
WKTV Severe Weather

Alivana Wellness Infusion Giveaway
Senior Send-Off brought to you by Herkimer College
18 Facets of Summer Photo Contest brought to you by Herkimer Diamond Mines
Looking for work or looking to hire? Check out the WKTV Job Fair!
Saluting Those Who Are Proud 2 Serve